← Open Payments lookup

ALEXIS BOURGEOIS: Open Payments

NPI 1346873403 · FRANKLIN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,226 in 48 payments from 18 companies in 2025. Trend: 2023 $460 · 2024 $171 · 2025 $1,226

Food & beverage: $1,226
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.7$304
ABBVIE INC.15$198
Alkermes, Inc.7$182
Vanda Pharmaceuticals Inc.2$131
Tarsus Pharmaceuticals, Inc.1$98
Axsome Therapeutics, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.2$39
Lundbeck LLC1$28
Braeburn Inc.1$26
Corium, LLC2$26

Products named: VRAYLAR, UZEDY, FANAPT, AUSTEDO XR, XDEMVY, ARISTADA, LYBALVI, REXULTI.

Industry payments across LA — which companies pay providers there.